But abstinence is really a high bar similar to requiring that an antidepressant create complete remission of despair or that an analgesic wholly reduce pain. Recognizing this limitation, the FDA encourages builders of opioid2 and stimulant3 use disorder remedies to discuss with FDA different strategies to measure improvements in drug https://www.sgvascularctr.com/what-is-clacs/